Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Lly crawled date : 2021 - 08 - 03 save search
Amgen Reports Second Quarter 2021 Financial Results
Published: 2021-08-03 (Crawled : 23:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
XNCR | $18.98 -0.47% -0.47% 470K
|
Health Technology
|
| O: 0.55%
H: 1.32%
C: 1.03%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: -0.05%
H: 1.86%
C: 1.67%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.21%
H: 4.53%
C: 4.06%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.4%
H: 1.51%
C: 1.38%
financial results results report
Eli Lilly in the News: COVID-19, Q2 and Ad Drama
Published: 2021-08-03 (Crawled : 15:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
covid covid-19
Iterative Scopes Raises $30 Million Series A Financing to Advance AI-Driven Precision Medicine for Gastroenterology
Published: 2021-08-03 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.27%
H: 1.02%
C: 0.96%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
Gennao Bio Appoints Dale L. Ludwig, Ph.D., as Chief Scientific Officer
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
Vanda Pharmaceuticals Closes Enrollment In The ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
VNDA | $4.97 -5.15% -5.43% 3.9M
|
Health Technology
|
| O: -1.6%
H: 1.86%
C: 1.68%
covid enroll
Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
ABCL | $3.92 0.0% 770K
|
|
| O: 1.14%
H: 0.0%
C: -1.56%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
RIGL | $1.06 -4.51% -4.72% 1.2M
|
Health Technology
|
| O: 0.5%
H: 0.5%
C: -6.44%
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: -1.21%
MRUS | $40.41 -1.56% -1.58% 240K
|
Health Technology
|
| O: 0.9%
H: 1.45%
C: 0.67%
financial results results liver
Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
Published: 2021-08-03 (Crawled : 10:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: -0.7%
H: 0.31%
C: 0.04%
covid baricitinib covid-19
First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
Published: 2021-08-03 (Crawled : 09:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
research
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.